1. Home
  2. ABCL vs IMKTA Comparison

ABCL vs IMKTA Comparison

Compare ABCL & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • IMKTA
  • Stock Information
  • Founded
  • ABCL 2012
  • IMKTA 1963
  • Country
  • ABCL Canada
  • IMKTA United States
  • Employees
  • ABCL N/A
  • IMKTA N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • IMKTA Food Chains
  • Sector
  • ABCL Health Care
  • IMKTA Consumer Staples
  • Exchange
  • ABCL Nasdaq
  • IMKTA Nasdaq
  • Market Cap
  • ABCL 1.1B
  • IMKTA 1.3B
  • IPO Year
  • ABCL 2020
  • IMKTA N/A
  • Fundamental
  • Price
  • ABCL $4.72
  • IMKTA $70.62
  • Analyst Decision
  • ABCL Strong Buy
  • IMKTA
  • Analyst Count
  • ABCL 5
  • IMKTA 0
  • Target Price
  • ABCL $8.00
  • IMKTA N/A
  • AVG Volume (30 Days)
  • ABCL 3.7M
  • IMKTA 104.9K
  • Earning Date
  • ABCL 11-03-2025
  • IMKTA 08-07-2025
  • Dividend Yield
  • ABCL N/A
  • IMKTA 0.93%
  • EPS Growth
  • ABCL N/A
  • IMKTA N/A
  • EPS
  • ABCL N/A
  • IMKTA 2.97
  • Revenue
  • ABCL $32,875,999.00
  • IMKTA $5,363,138,171.00
  • Revenue This Year
  • ABCL $16.99
  • IMKTA N/A
  • Revenue Next Year
  • ABCL $63.73
  • IMKTA N/A
  • P/E Ratio
  • ABCL N/A
  • IMKTA $23.63
  • Revenue Growth
  • ABCL N/A
  • IMKTA N/A
  • 52 Week Low
  • ABCL $1.89
  • IMKTA $58.92
  • 52 Week High
  • ABCL $5.82
  • IMKTA $75.63
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 58.52
  • IMKTA 63.41
  • Support Level
  • ABCL $4.32
  • IMKTA $68.19
  • Resistance Level
  • ABCL $4.85
  • IMKTA $71.88
  • Average True Range (ATR)
  • ABCL 0.28
  • IMKTA 1.58
  • MACD
  • ABCL 0.05
  • IMKTA 0.01
  • Stochastic Oscillator
  • ABCL 87.25
  • IMKTA 74.29

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: